• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

参与派对:PARP 在 DNA 修复(和转录?)过程中对 KDM5A 的调控。

Joining the PARty: PARP Regulation of KDM5A during DNA Repair (and Transcription?).

机构信息

Department of Molecular Biosciences, The University of Texas at Austin, Austin, TX, 78712, The University of Texas at Austin, Austin, Texas, USA.

Department of Chemistry, University of Utah, Salt Lake City, Utah, USA.

出版信息

Bioessays. 2022 Jul;44(7):e2200015. doi: 10.1002/bies.202200015. Epub 2022 May 9.

DOI:10.1002/bies.202200015
PMID:35532219
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9233061/
Abstract

The lysine demethylase KDM5A collaborates with PARP1 and the histone variant macroH2A1.2 to modulate chromatin to promote DNA repair. Indeed, KDM5A engages poly(ADP-ribose) (PAR) chains at damage sites through a previously uncharacterized coiled-coil domain, a novel binding mode for PAR interactions. While KDM5A is a well-known transcriptional regulator, its function in DNA repair is only now emerging. Here we review the molecular mechanisms that regulate this PARP1-macroH2A1.2-KDM5A axis in DNA damage and consider the potential involvement of this pathway in transcription regulation and cancer. Using KDM5A as an example, we discuss how multifunctional chromatin proteins transition between several DNA-based processes, which must be coordinated to protect the integrity of the genome and epigenome. The dysregulation of chromatin and loss of genome integrity that is prevalent in human diseases including cancer may be related and could provide opportunities to target multitasking proteins with these pathways as therapeutic strategies.

摘要

赖氨酸去甲基酶 KDM5A 与 PARP1 和组蛋白变体 macroH2A1.2 合作,调节染色质以促进 DNA 修复。事实上,KDM5A 通过以前未被表征的卷曲螺旋结构域与损伤部位的聚(ADP-核糖)(PAR)链结合,这是 PAR 相互作用的一种新结合模式。虽然 KDM5A 是一种众所周知的转录调节剂,但它在 DNA 修复中的作用直到现在才显现出来。在这里,我们综述了调控这个 PARP1-macroH2A1.2-KDM5A 轴在 DNA 损伤中的分子机制,并考虑了该途径在转录调控和癌症中的潜在作用。我们以 KDM5A 为例,讨论了多功能染色质蛋白如何在几种基于 DNA 的过程之间转换,这些过程必须协调一致,以保护基因组和表观基因组的完整性。在包括癌症在内的人类疾病中普遍存在的染色质失调和基因组完整性丧失可能存在关联,并可能为靶向这些途径的多功能蛋白提供治疗策略的机会。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/48f8/9233061/4a72b33b65b3/nihms-1803494-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/48f8/9233061/17438f39c05f/nihms-1803494-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/48f8/9233061/dc594a7016f0/nihms-1803494-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/48f8/9233061/03ec56399381/nihms-1803494-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/48f8/9233061/8d667e02c0f7/nihms-1803494-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/48f8/9233061/4a72b33b65b3/nihms-1803494-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/48f8/9233061/17438f39c05f/nihms-1803494-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/48f8/9233061/dc594a7016f0/nihms-1803494-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/48f8/9233061/03ec56399381/nihms-1803494-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/48f8/9233061/8d667e02c0f7/nihms-1803494-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/48f8/9233061/4a72b33b65b3/nihms-1803494-f0006.jpg

相似文献

1
Joining the PARty: PARP Regulation of KDM5A during DNA Repair (and Transcription?).参与派对:PARP 在 DNA 修复(和转录?)过程中对 KDM5A 的调控。
Bioessays. 2022 Jul;44(7):e2200015. doi: 10.1002/bies.202200015. Epub 2022 May 9.
2
Poly(ADP-ribose) binding and macroH2A mediate recruitment and functions of KDM5A at DNA lesions.聚(ADP-核糖)结合和巨组蛋白 H2A 介导 KDM5A 在 DNA 损伤处的募集和功能。
J Cell Biol. 2021 Jul 5;220(7). doi: 10.1083/jcb.202006149. Epub 2021 May 18.
3
Histone demethylase KDM5A regulates the ZMYND8-NuRD chromatin remodeler to promote DNA repair.组蛋白去甲基化酶KDM5A调节ZMYND8-NuRD染色质重塑因子以促进DNA修复。
J Cell Biol. 2017 Jul 3;216(7):1959-1974. doi: 10.1083/jcb.201611135. Epub 2017 Jun 1.
4
A macrodomain-containing histone rearranges chromatin upon sensing PARP1 activation.一种含宏结构域的组蛋白在感知PARP1激活后会重新排列染色质。
Nat Struct Mol Biol. 2009 Sep;16(9):923-9. doi: 10.1038/nsmb.1664. Epub 2009 Aug 13.
5
Poly(ADP-ribose) polymerases PARP1 and PARP2 modulate topoisomerase II beta (TOP2B) function during chromatin condensation in mouse spermiogenesis.多聚(ADP-核糖)聚合酶 PARP1 和 PARP2 在小鼠精子发生过程中的染色质浓缩过程中调节拓扑异构酶 IIβ(TOP2B)的功能。
Biol Reprod. 2011 May;84(5):900-9. doi: 10.1095/biolreprod.110.090035. Epub 2011 Jan 12.
6
MacroH2A1 Regulation of Poly(ADP-Ribose) Synthesis and Stability Prevents Necrosis and Promotes DNA Repair.组蛋白 H2A1 调控多聚(ADP-核糖)合成和稳定性,防止细胞坏死并促进 DNA 修复。
Mol Cell Biol. 2019 Dec 11;40(1). doi: 10.1128/MCB.00230-19.
7
p21CDKN1A Regulates the Binding of Poly(ADP-Ribose) Polymerase-1 to DNA Repair Intermediates.p21CDKN1A调控聚(ADP - 核糖)聚合酶-1与DNA修复中间体的结合。
PLoS One. 2016 Jan 5;11(1):e0146031. doi: 10.1371/journal.pone.0146031. eCollection 2016.
8
Poly(ADP-ribose) contributes to an association between poly(ADP-ribose) polymerase-1 and xeroderma pigmentosum complementation group A in nucleotide excision repair.聚(ADP-核糖)有助于核苷酸切除修复中多聚(ADP-核糖)聚合酶 1 和着色性干皮病互补组 A 之间的关联。
J Biol Chem. 2012 Nov 16;287(47):39824-33. doi: 10.1074/jbc.M112.393504. Epub 2012 Oct 4.
9
Chromodomain helicase DNA-binding protein 4 (CHD4) regulates homologous recombination DNA repair, and its deficiency sensitizes cells to poly(ADP-ribose) polymerase (PARP) inhibitor treatment.染色质解旋酶 DNA 结合蛋白 4(CHD4)调节同源重组 DNA 修复,其缺乏使细胞对聚(ADP-核糖)聚合酶(PARP)抑制剂治疗敏感。
J Biol Chem. 2012 Feb 24;287(9):6764-72. doi: 10.1074/jbc.M111.287037. Epub 2012 Jan 4.
10
Mechanistic insight into the role of Poly(ADP-ribosyl)ation in DNA topology modulation and response to DNA damage.聚(ADP-核糖)化在 DNA 拓扑结构调节和 DNA 损伤反应中的作用的机制见解。
Mutagenesis. 2020 Feb 13;35(1):107-118. doi: 10.1093/mutage/gez045.

引用本文的文献

1
Targeting the DNA damage response (DDR) of cancer cells with natural compounds derived from and other plants.利用从[具体来源]和其他植物中提取的天然化合物靶向癌细胞的DNA损伤反应(DDR)。
J Ginseng Res. 2025 Jan;49(1):1-11. doi: 10.1016/j.jgr.2024.04.001. Epub 2024 Apr 9.
2
The Function of H2A Histone Variants and Their Roles in Diseases.组蛋白变体 H2A 的功能及其在疾病中的作用。
Biomolecules. 2024 Aug 12;14(8):993. doi: 10.3390/biom14080993.
3
PARticular MARks: Histone ADP-ribosylation and the DNA damage response.特殊标记:组蛋白 ADP-ribosylation 和 DNA 损伤反应。

本文引用的文献

1
Appropriate Selection of PARP Inhibitors in Ovarian Cancer.卵巢癌中PARP抑制剂的合理选择
Curr Treat Options Oncol. 2022 Jun;23(6):887-903. doi: 10.1007/s11864-022-00938-4. Epub 2022 Apr 12.
2
Poly(ADP-ribosylation) of P-TEFb by PARP1 disrupts phase separation to inhibit global transcription after DNA damage.PARP1 对 P-TEFb 的多聚(ADP-核糖)化破坏相分离,从而抑制 DNA 损伤后的全局转录。
Nat Cell Biol. 2022 Apr;24(4):513-525. doi: 10.1038/s41556-022-00872-5. Epub 2022 Apr 7.
3
Histone H2A variants: Diversifying chromatin to ensure genome integrity.
DNA Repair (Amst). 2024 Aug;140:103711. doi: 10.1016/j.dnarep.2024.103711. Epub 2024 Jun 22.
组蛋白 H2A 变体:多样化的染色质以确保基因组完整性。
Semin Cell Dev Biol. 2023 Feb 15;135:59-72. doi: 10.1016/j.semcdb.2022.03.011. Epub 2022 Mar 21.
4
The expanding universe of PARP1-mediated molecular and therapeutic mechanisms.PARP1 介导的分子和治疗机制的不断扩展的领域。
Mol Cell. 2022 Jun 16;82(12):2315-2334. doi: 10.1016/j.molcel.2022.02.021. Epub 2022 Mar 9.
5
The Making and Breaking of Serine-ADP-Ribosylation in the DNA Damage Response.DNA损伤反应中丝氨酸-ADP-核糖基化的形成与破坏
Front Cell Dev Biol. 2021 Nov 15;9:745922. doi: 10.3389/fcell.2021.745922. eCollection 2021.
6
HPF1 dynamically controls the PARP1/2 balance between initiating and elongating ADP-ribose modifications.HPF1 动态控制 PARP1/2 之间起始和延伸 ADP-ribose 修饰的平衡。
Nat Commun. 2021 Nov 18;12(1):6675. doi: 10.1038/s41467-021-27043-8.
7
Chaperoning histones at the DNA repair dance.在 DNA 修复之舞中为组蛋白伴舞。
DNA Repair (Amst). 2021 Dec;108:103240. doi: 10.1016/j.dnarep.2021.103240. Epub 2021 Oct 13.
8
Making Connections: Integrative Signaling Mechanisms Coordinate DNA Break Repair in Chromatin.建立联系:整合信号机制协调染色质中的DNA断裂修复
Front Genet. 2021 Sep 29;12:747734. doi: 10.3389/fgene.2021.747734. eCollection 2021.
9
The regulatory landscape of the human HPF1- and ARH3-dependent ADP-ribosylome.人类 HPF1 和 ARH3 依赖的 ADP-ribosylome 的调控景观。
Nat Commun. 2021 Oct 8;12(1):5893. doi: 10.1038/s41467-021-26172-4.
10
Pharmacological inhibition of KDM5A for cancer treatment.KDM5A 的药物抑制在癌症治疗中的作用。
Eur J Med Chem. 2021 Dec 15;226:113855. doi: 10.1016/j.ejmech.2021.113855. Epub 2021 Sep 15.